PT-141 10mg

PT-141 (Bremelanotide)

PT-141 (bremelanotide) is a cyclic melanocortin-receptor research peptide derived from the α-MSH family. Laboratories use it to investigate melanocortin signalling, receptor selectivity, and downstream second-messenger pathways in vitro under controlled, non-clinical conditions.
For laboratory research only. Not for human use.

PT-141 Key features

• Cyclic analogue designed for studies of melanocortin receptor pharmacology (e.g., receptor binding and signalling readouts).
• Supplied as a lyophilised solid for stability and straightforward storage.
• Unit size: 10 mg per vial.
• Every batch released only after stringent quality checks.

Specifications

• Product name: PT-141
• Synonyms: Bremelanotide; SZT-brem; melanocortin analogue
• Class: Cyclic heptapeptide analogue of α-MSH (melanocortin family)
• CAS (reference): 189691-06-3
• Form: Lyophilised powder
• Unit size: 10 mg
• Appearance: White to off-white solid